SMARCA4-deficient non-small cell lung cancer (NSCLC) is an uncommon primary malignant epithelial tumor originating in the lung, classified as a distinct clinicopathologic entity in the World Health Organization Classification of Thoracic Tumors, published in May 2021. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.